Dulcolax and Novalgin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Novalgin (metamizole). Common drug interactions include tumour pain among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Novalgin. It is created by eHealthMe based on reports of 84 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Novalgin?

Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 10,177 Novalgin users. Check the latest studies of Novalgin.

On Jul, 15, 2026

84 people who take Dulcolax and Novalgin together, and have interactions are studied.

Dulcolax and Novalgin drug interactions.

What are the common drug interactions of Dulcolax and Novalgin, by gender? *:

female:

Tumour pain
Abdominal pain
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Leukopenia (less number of white blood cells in blood)
Dizziness
Headache (pain in head)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Infection susceptibility increased
Mobility decreased (ability to move is reduced)
Tumour flare (temporary increase in symptoms from a cancer after starting treatment)

male:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Colitis (inflammation of colon)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Hemiplegia (paralysis of one side of the body)
Hepatic enzyme increased
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Procedural headache
White blood cell count decreased
Agitation (state of anxiety or nervous excitement)
Blood bilirubin increased

What are the common drug interactions of Dulcolax and Novalgin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug eruption (adverse drug reaction of the skin)

30-39:

Pancreas infection

40-49:

n/a

50-59:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood creatinine increased
Blood lactate dehydrogenase increased
Blood urea increased
Leukocytosis (increased white blood cells)
Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
Pneumonia
Pruritus (severe itching of the skin)
Rash
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

60+:

General physical health deterioration (weak health status)
Platelet count decreased
White blood cell count decreased
Agitation (state of anxiety or nervous excitement)
Blood bilirubin increased
Nausea (feeling of having an urge to vomit)
Hot flush (sudden feelings of heat)
Hyperhidrosis (abnormally increased sweating)
Hypertension (high blood pressure)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

What are the existing conditions these people have? *

High Blood Pressure: 44 people, 52.38%
Sleep Disorder: 25 people, 29.76%
Anaemia (lack of blood): 24 people, 28.57%
Acute Kidney Failure: 19 people, 22.62%
Nausea (feeling of having an urge to vomit): 16 people, 19.05%
Lung Cancer - Non-Small Cell (lung cancer): 16 people, 19.05%
Depression: 15 people, 17.86%
Hypokalemia (low potassium): 14 people, 16.67%
Infection: 14 people, 16.67%
Arrhythmias (irregular heartbeat): 13 people, 15.48%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Novalgin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously